TurnerTrends Stock Rating Report for AKRX
Data valid for week beginning January 05, 2009
|
AKRX [News]
|
Akorn Inc
|
Company Profile
"Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in areas, such as ophthalmology, rheumatology, anesthesia, and antidotes primarily in the United States. The company operates in four segments: Ophthalmic, Hospital Drugs and Injectables, Biologics and Vaccines, and Contract Services. The Ophthalmic segment offers a line of diagnostic and therapeutic ophthalmic pharmaceutical products. Its diagnostic products include mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are primarily used in the office setting. This segment’s therapeutic products comprise antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants-antihistamines, and anti-edema medications. Its non-pharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The Hospital Drugs and Injectables segment provides a line of injectable pharmaceutical products, including antidotes, anesthesia, and products used in the treatment of rheumatoid arthritis and pain management. These products are marketed to hospitals through wholesalers and other national account customers, as well as directly to medical specialists. The Biologics and Vaccines segment offers adult Tetanus-Diphtheria vaccines, which are marketed directly to hospitals and physicians, as well as through wholesalers and national distributors. The Contract Services segment manufactures products for third party pharmaceutical and biotechnology customers. The company serves physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and pharmaceutical companies. It has strategic partnerships with Strides Arcolab Limited- Serum Institute of India, Ltd.- Hameln Pharmaceuticals- and Cipla, Ltd. Akorn, Inc. was founded in 1971 and is headquartered in Buffalo Grove, Illinois."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Fri, 2 Jan 2009 15:47:00 Etc/GMT | PowerRatings Weekly Recap: GPRO, RGLD, TEVA, CEPH (TradingMarkets.com) | | Wed, 31 Dec 2008 14:23:43 Etc/GMT | UPDATE - Akorn-Strides gets FDA nod for two generic antibiotics (at Reuters) | | Wed, 31 Dec 2008 13:28:19 Etc/GMT | Akorn's generic antibiotic approved by FDA (AP) | | Wed, 31 Dec 2008 12:00:00 Etc/GMT | Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package (Business Wire) | | Tue, 30 Dec 2008 14:29:10 Etc/GMT | Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008 (at Seeking Alpha) | | Tue, 23 Dec 2008 22:32:32 Etc/GMT | Biovail settles lawsuits with ex-analyst Treppel (AP) | | Tue, 16 Dec 2008 12:00:00 Etc/GMT | Akorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl (Business Wire) | | Fri, 12 Dec 2008 14:01:48 Etc/GMT | FDA approves generic drug application from Akorn (AP) | | Fri, 12 Dec 2008 12:00:00 Etc/GMT | Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3% (Business Wire) | | Mon, 24 Nov 2008 21:25:12 Etc/GMT | Investing in India's Generic Drug Market (at Seeking Alpha) | | Mon, 24 Nov 2008 20:13:48 Etc/GMT | Akorn, Bioluz team up to produce, market drugs (AP) | | Mon, 24 Nov 2008 12:00:00 Etc/GMT | Akorn, Inc. Signs Memorandum of Understanding with Bioluz S.A. for Five Premix Products (Business Wire) | | Thu, 20 Nov 2008 12:00:00 Etc/GMT | Akorn Enters into a Five Year Contract Manufacturing Agreement to Supply an Ophthalmic Product (Business Wire) | | Wed, 19 Nov 2008 14:04:16 Etc/GMT | AKORN INC Financials (EDGAR Online Financials) | | Tue, 18 Nov 2008 10:01:29 Etc/GMT | Akorn, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha) | | Mon, 10 Nov 2008 22:12:55 Etc/GMT | AKORN INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Thu, 6 Nov 2008 12:00:00 Etc/GMT | Akorn, Inc. to Present at the Credit Suisse Healthcare Conference (Business Wire) | | Wed, 5 Nov 2008 11:01:14 Etc/GMT | AKORN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online) | | Tue, 4 Nov 2008 14:24:54 Etc/GMT | New Star Analyst Rankings for AKORN INC (StarMine) | | Tue, 4 Nov 2008 11:01:04 Etc/GMT | AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online) | News provided by Yahoo! Finance |
|
